Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
Mariela A. Moreno Ayala, Timothy F. Campbell, Chen‐Yu Zhang, et al.
Immunity (2023) Vol. 56, Iss. 7, pp. 1613-1630.e5
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 95
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 64
Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine
Shogo Kumagai, Kota Itahashi, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 337-353
Closed Access | Times Cited: 43
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Yu Li, Cangang Zhang, Aimin Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity
Siyuan You, Shuqin Li, Lingsu Zeng, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1415-1433.e12
Closed Access | Times Cited: 22
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes
Christine Bender, Alice Wiedeman, Alex Hu, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 746
Closed Access | Times Cited: 13
Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 12
Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study
Jingyi Tang, Shengke Zhang, Lai Jiang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4219-4231
Open Access | Times Cited: 12
Stability and plasticity of regulatory T cells in health and disease
Eugenio Contreras-Castillo, Verónica Yutsil García-Rasilla, María Guadalupe García-Patiño, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 1, pp. 33-53
Open Access | Times Cited: 10
VEGFR affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer
Kaiyuan Hui, Changhong Dong, Chenxi Hu, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 9
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 8
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma
Xiyu Song, Yumeng Zhu, Wenwen Geng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010183-e010183
Open Access | Times Cited: 1
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors
Mikhaël Attias, Ciriaco A. Piccirillo
British Journal of Pharmacology (2024)
Open Access | Times Cited: 7
Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry
Tsunenori Ouchida, Yu Isoda, Tomohiro Tanaka, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2024) Vol. 43, Iss. 3, pp. 90-95
Open Access | Times Cited: 6
The landscape of cancer-rewired GPCR signaling axes
Chakit Arora, Marin Matic, Luisa Bisceglia, et al.
Cell Genomics (2024) Vol. 4, Iss. 5, pp. 100557-100557
Open Access | Times Cited: 6
Regulatory T Cells for Control of Autoimmunity
Ryoji Kawakami, Shimon Sakaguchi
Advances in experimental medicine and biology (2024), pp. 67-82
Closed Access | Times Cited: 5
ZBTB46 coordinates angiogenesis and immunity to control tumor outcome
Ashraf Ul Kabir, Carisa Zeng, Madhav Subramanian, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1546-1554
Closed Access | Times Cited: 5
SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration
Xiaoqian Liu, Kuai Liu, Yuxi Wang, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114458-114458
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top